标题
Denosumab treatment for fibrous dysplasia
作者
关键词
-
出版物
JOURNAL OF BONE AND MINERAL RESEARCH
Volume 27, Issue 7, Pages 1462-1470
出版商
Wiley
发表日期
2012-03-20
DOI
10.1002/jbmr.1603
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Effects of Denosumab Treatment and Discontinuation on Bone Mineral Density and Bone Turnover Markers in Postmenopausal Women with Low Bone Mass
- (2011) Henry G. Bone et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Denosumab versus zoledronic acid for treatment of bone metastases in men with castration-resistant prostate cancer: a randomised, double-blind study
- (2011) Karim Fizazi et al. LANCET
- Atypical fractures of the femur and bisphosphonate therapy
- (2010) Andrea Giusti et al. BONE
- The McCune-Albright syndrome: a lethal gene surviving by mosaicism
- (2010) R. Happle CLINICAL GENETICS
- Effects of denosumab on bone histomorphometry: The FREEDOM and STAND studies
- (2010) Ian R Reid et al. JOURNAL OF BONE AND MINERAL RESEARCH
- Prkar1a is an osteosarcoma tumor suppressor that defines a molecular subclass in mice
- (2010) Sam D. Molyneux et al. JOURNAL OF CLINICAL INVESTIGATION
- Denosumab Compared With Zoledronic Acid for the Treatment of Bone Metastases in Patients With Advanced Breast Cancer: A Randomized, Double-Blind Study
- (2010) Alison T. Stopeck et al. JOURNAL OF CLINICAL ONCOLOGY
- Skeletal progenitors and the GNAS gene: fibrous dysplasia of bone read through stem cells
- (2010) Mara Riminucci et al. JOURNAL OF MOLECULAR ENDOCRINOLOGY
- Denosumab in patients with giant-cell tumour of bone: an open-label, phase 2 study
- (2010) David Thomas et al. LANCET ONCOLOGY
- RANK ligand mediates progestin-induced mammary epithelial proliferation and carcinogenesis
- (2010) Eva Gonzalez-Suarez et al. NATURE
- Osteoclast differentiation factor RANKL controls development of progestin-driven mammary cancer
- (2010) Daniel Schramek et al. NATURE
- Increased RANKL expression is related to tumour migration and metastasis of renal cell carcinomas
- (2009) Shuji Mikami et al. JOURNAL OF PATHOLOGY
- Denosumab Treatment of Prostate Cancer With Bone Metastases and Increased Urine N-Telopeptide Levels After Therapy With Intravenous Bisphosphonates: Results of a Randomized Phase II Trial
- (2009) Karim Fizazi et al. JOURNAL OF UROLOGY
- Comparison of Effects of the Bisphosphonate Alendronate Versus the RANKL Inhibitor Denosumab on Murine Fracture Healing
- (2008) Louis C Gerstenfeld et al. JOURNAL OF BONE AND MINERAL RESEARCH
- McCune-Albright syndrome
- (2008) Claudia E Dumitrescu et al. Orphanet Journal of Rare Diseases
- RANK ligand as a therapeutic target for bone metastases and multiple myeloma
- (2007) G. David Roodman et al. CANCER TREATMENT REVIEWS
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationPublish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn More